Indaptus Therapeutics Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
INDP$2.90-7.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance Sheets
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $7,380,686 | $13,362,053 |
| Prepaid expenses and other current assets | 248,737 | 633,156 |
| Total current assets | 7,629,423 | 13,995,209 |
| Non-current assets: | ||
| Property and equipment, net | - | 735 |
| Right-of-use asset | 105,655 | 173,206 |
| Other assets | 504,728 | 754,728 |
| Total non-current assets | 610,383 | 928,669 |
| Total assets | $8,239,806 | $14,923,878 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable and other current liabilities | $2,128,491 | $2,672,327 |
| Operating lease liability, current portion | 103,982 | 101,705 |
| Total current liabilities | 2,232,473 | 2,774,032 |
| Non-current liabilities: | ||
| Operating lease liability, net of current portion | 4,007 | 73,348 |
| Total non-current liabilities | 4,007 | 73,348 |
| Total liabilities | 2,236,480 | 2,847,380 |
| Commitments and contingencies (Note 7) | - | - |
| Stockholders’ equity: | ||
| Common stock: $0.01 par value, 200,000,000 shares authorized as of September 30, 2024 and December 31, 2023; 10,196,884 shares issued and outstanding as of September 30, 2024 and 8,401,047 shares issued and outstanding as of December 31, 2023 | 101,969 | 84,011 |
| Additional paid in capital | 62,209,493 | 57,409,643 |
| Accumulated deficit | (56,308,136) | (45,417,156) |
| Total stockholders’ equity | 6,003,326 | 12,076,498 |
| Total liabilities and stockholders’ equity | $8,239,806 | $14,923,878 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.